ASH 2018: A first stem cell transplant after CAR T-Cell therapy reduces relapses in ALL
In a new study presented at ASH 2018 in San Diego, patients with ALL who received a…
Browsing: ASH 2018
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…
ASH 2018: Rapid genetic screening shows feasibility of precision medicine for acute myeloid leukaemia
A new study presented at ASH 2018 in San Diego demonstrates it is feasible – and helpful…
ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes
Researchers have presented at ASH 2018 in San Diego the model of using machine learning – a…
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…
ASH 2018: Daratumumab increases progression-free survival in transplant-ineligible multiple myeloma
Interim results from a large international phase III clinical trial show that adding the immunotherapy…
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…
ASH 2018: Disruptions in the gut microbiota before hematopoietic cell transplantation associated with worse outcomes
A new study presented at ASH 2018 in San Diego reports the likelihood of complications from a…
ASH 2018: New research on stem cell transplantation for myeloid cancers
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation was the focus…
ASH 2018: Cancer patients show reduced risk of harmful clots while taking direct oral anticoagulants
A new study suggests taking a DOAC can reduce the risk of harmful blood clots…